Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR DMD) study will compare
three ways of giving corticosteroids to boys with Duchenne muscular dystrophy (DMD) to
determine which of the three ways increases muscle strength the most, and which causes the
fewest side effects. Using the results of this study, the investigators aim to provide
patients and families with clearer information about the best way to take these drugs.
Phase:
Phase 3
Details
Lead Sponsor:
University of Rochester
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) Newcastle University University Medical Center Freiburg